[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@OzmosiHealth Ozmosi

Ozmosi posts on X about more info, $kymr, kymera, $rhhby the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

X Week XXXXXX +84%
X Month XXXXXXX -XX%
X Months XXXXXXX +63%
X Year XXXXXXXXX +36%

Mentions: XXX #

X Week XXX +9.10%
X Month XXX -XX%
X Months XXXXX +26%
X Year XXXXX +7.90%

Followers: XXXXX #

X Week XXXXX +1.90%
X Month XXXXX +3.20%
X Months XXXXX +29%
X Year XXXXX +49%

CreatorRank: XXXXXXX #

Social Influence

Social category influence stocks XXXX% cryptocurrencies XXXX% countries XXXX% currencies XXXX% technology brands XXXX% finance XXXX%

Social topic influence more info #232, $kymr #21, kymera #11, $rhhby #5, $fate #2, $xene 1.1%, $gern #3, $tern #32, $glpg #2, $gmab #4

Top accounts mentioned or mentioned by @saylor_monty

Top Social Posts

Top posts by engagements in the last XX hours

"$IONS +0.20% today as Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD) More Info:"
X Link 2025-12-02T15:18Z 3018 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LYRA Lyra Therapeutics will present Phase X Sinusitis Data for Mometasone furoate (Corticosteroid Hormone Receptor Agonist - Small Molecule) tomorrow 👀"
X Link 2025-10-12T11:12Z 3011 followers, XXX engagements

"$ARGX argenx announced they will present P2 Amyotrophic Lateral Sclerosis results in 1H26 for Adimanebart More Info:"
X Link 2025-11-03T15:09Z 3011 followers, XXX engagements

"$ARGX argenx announced they will present P3 Sjogren's Syndrome results in YE27 for Efgartigimod More Info:"
X Link 2025-11-03T15:09Z 3011 followers, XXX engagements

"$ACLX Arcellx announced they will present P2 Multiple Myeloma results on 2025-12-06 for Anitocabtagene autoleucel More Info:"
X Link 2025-11-04T20:55Z 3011 followers, XXX engagements

"$XENE Xenon announced they will present P3 Epilepsy results in 1H26 for Azetukalner More Info:"
X Link 2025-11-04T20:56Z 3010 followers, XXX engagements

"$NMRA Neumora announced they will present P3 Depressive Disorder Major results in 1Q26 for Navacaprant More Info:"
X Link 2025-11-07T21:35Z 3011 followers, XXX engagements

"$PRTA Prothena presented P2 Transthyretin Amyloidosis results on 2025-11-11 for Coramitug More Info:"
X Link 2025-11-12T20:37Z 3011 followers, XXX engagements

"$RADX -XXXX% today as Radiopharm Theranostics Announces XX% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases More Info:"
X Link 2025-11-17T15:19Z 3011 followers, XXX engagements

"$CGON CG Oncology announced they will present P3 Bladder CancerMuscle Cancer results in 4Q25 for Cretostimogene grenadenorepvec More Info:"
X Link 2025-11-17T21:14Z 3011 followers, XXX engagements

"$ADPT +6.07% today as Adaptive Biotechnologies Announces Nearly XX Abstracts Featuring clonoSEQ MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting More Info:"
X Link 2025-11-24T14:58Z 3011 followers, XXX engagements

"$KYMR +0.24% today as Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader More Info:"
X Link 2025-11-25T14:54Z 3011 followers, XXX engagements

"$XENE +1.46% today as Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025 More Info:"
X Link 2025-11-25T14:54Z 3011 followers, XXX engagements

"$SNY +2.48% today as Press Release: Sanofi and Regeneron's Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria More Info:"
X Link 2025-11-25T14:54Z 3011 followers, XXX engagements

"$4523 as Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status More Info:"
X Link 2025-11-25T14:54Z 3009 followers, XXX engagements

"$CELC Celcuity announced they will present P3 Breast Cancer results on 2025-12-11 for Gedatolisib More Info:"
X Link 2025-12-01T19:34Z 3011 followers, XXX engagements

"$HCM HUTCHMED announced they will present P3 ThrombocytopeniaPurpura Thrombocytopenic Idiopathic results on 2025-12-08 for Sovleplenib More Info:"
X Link 2025-12-01T19:34Z 3009 followers, XXX engagements

"$JANX Janux Therapeutics presented P1 Prostate Cancer results on 2025-12-01 for JANX-007 More Info:"
X Link 2025-12-02T21:06Z 3010 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Renal Cell Carcinoma Data for Fruquintinib (VEGFR Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-04T11:12Z 3011 followers, XXX engagements

"$HALO -XXXX% today as Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany More Info:"
X Link 2025-12-04T19:34Z 3010 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $IRON Disc Medicine will present Phase X AnemiaMyelofibrosis Data for DISC-0974 (HJV Antagonist - Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3009 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ARVN Arvinas will present Preclinical Lymphoma Non-HodgkinLymphoma B-CellT-Cell Peripheral LymphomaImmunoblastic Lymphadenopathy Data for Zaloblideg (BCL6 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $GERN Geron will present Phase X Myelodysplastic Syndrome Data for Imetelstat (telomerase Inhibitor - Nucleic Acid) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $NUVL Nuvalent will present Phase X Non-Small-Cell Lung Cancer Data for Zidesamtinib (ROS1 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ARVN Arvinas will present Preclinical Diffuse Large B-Cell Lymphoma Data for Zaloblideg (BCL6 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 3009 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $XENE Xenon will present Phase X Epilepsy Data for Azetukalner (KCNQ2 OpenerKCNQ3 Opener - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Oncology Solid Tumor Unspecified Data for HMPL-A83 (CD47 Inhibitor - Antibody) tomorrow 👀"
X Link 2025-12-06T11:12Z 3011 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $TERN Terns will present Phase X Chronic Myeloid Leukemia Data for TERN-701 (Bcr-Abl Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-07T11:12Z 3011 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $KURA Kura Oncology will present Phase X Acute Myeloid Leukemia Data for Ziftomenib (MEN1 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-07T11:12Z 3011 followers, 1247 engagements

"$ONC +1.67% today as BRUKINSA Delivers Landmark XX% 6-Year PFS in Patients with Treatment-Nave Chronic Lymphocytic Leukemia More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$CGEM +17.66% today as Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049 Novel FLT3xCD3 T Cell Engager in Oral Presentation at the 67th ASH Meeting More Info:"
X Link 2025-12-08T21:22Z 3009 followers, XXX engagements

"$CRDF +10.61% today as Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 More Info:"
X Link 2025-12-08T21:22Z 3009 followers, XXX engagements

"$TERN +36.70% today as Terns Highlights Additional Positive Phase X Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements

"$KYMR Kymera Therapeutics announced they will present P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements

"$BIIB Biogen presented P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements

"$STOK Stoke Therapeutics presented P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements

"$ZLAB -XXXX% today as Zai Lab Announces Updated Phase X Data for Zocilurtatug Pelitecan (formerly ZL-1310) Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer and Initiation of Global Phase X Registrational Study More Info:"
X Link 2025-10-24T14:09Z 3009 followers, XXX engagements

"$ARGX -XXXX% today as argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada More Info:"
X Link 2025-11-05T15:50Z 3013 followers, XXX engagements

"$DAWN Day One Biopharmaceuticals announced they will present P2 Glioma results on 2025-11-23 for Tovorafenib More Info:"
X Link 2025-11-11T18:34Z 3010 followers, XXX engagements

"$BOLT Bolt Biotherapeutics announced they will present P1 AdenocarcinomaGastrointestinal CancerEsophageal Cancer results in 3Q26 for BDC-4182 More Info:"
X Link 2025-11-13T19:05Z 3009 followers, XXX engagements

"$CTNM -XXXX% today as Contineum Therapeutics Reports Topline Data From Its Phase X PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) More Info:"
X Link 2025-11-20T21:29Z 3013 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $DAWN Day One Biopharmaceuticals will present Phase X Glioma Data for Tovorafenib (RAFk Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-11-22T11:12Z 3010 followers, XXX engagements

"$ONC +2.05% today as U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma More Info:"
X Link 2025-11-26T15:07Z 3010 followers, XXX engagements

"$BIIB Biogen presented P3 Alzheimer Disease results on 2025-12-02 for Lecanemab More Info:"
X Link 2025-12-03T20:59Z 3010 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Myelofibrosis Data for INCB-160058 (JAK2 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 3013 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $IRON Disc Medicine will present Phase X Polycythemia Vera Data for DISC-3405 (TMPRSS6 Antagonist - Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3009 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $REGN Regeneron will present Phase X Paroxysmal Nocturnal Hemoglobinuria Data for Pozelimab (C5 Inhibitor - Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3010 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $REGN Regeneron will present Phase X Diffuse Large B-Cell Lymphoma Data for Odronextamab (CD20 AntagonistCD3 Inhibitor - Bispecific Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3010 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ALLO Allogene Therapeutics will present Phase X Lymphoma B-Cell Data for Cemacabtagene ansegedleucel (CAR-TCD19 - Allogeneic CAR-T) tomorrow 👀"
X Link 2025-12-06T11:12Z 3010 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $GLPG Galapagos will present Phase X Mantle-Cell Lymphoma Data for GLPG-5101 (CAR-TCD19 - Autologous CAR-T) tomorrow 👀"
X Link 2025-12-06T11:12Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $GLPG Galapagos will present Phase X Lymphoma Non-Hodgkin Data for GLPG-5101 (CAR-TCD19 - Autologous CAR-T) tomorrow 👀"
X Link 2025-12-07T11:12Z 3014 followers, XXX engagements

"$KYMR +50.38% today as Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis More Info:"
X Link 2025-12-08T15:14Z 3014 followers, XXX engagements

"$WVE +96.94% today as Wave Life Sciences Announces Positive Interim Data from Phase X INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$RXRX +0.43% today as Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$PHGE -XXXXX% today as BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$GPCR +174.36% today as Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$FATE -XXXX% today as Fate Therapeutics Presents Updated Phase X Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$NRIX +14.15% today as Nurix Therapeutics Presents New Data from the Phase X Trial of Bexobrutideg (NX-5948) in Waldenstrm Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$RHHBY +1.50% today as Roche's Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study More Info:"
X Link 2025-12-08T15:14Z 3014 followers, XXX engagements

"$MBRX +4.57% today as Moleculin Announces New Annamycin Collaboration in Brain Tumors More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements

"$COGT +0.54% today as Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) More Info:"
X Link 2025-12-08T15:14Z 3013 followers, XXX engagements

"$SNDX -XXXX% today as Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum More Info:"
X Link 2025-12-08T15:15Z 3010 followers, XXX engagements

"$MRK -XXXX% today as Saskatchewan Adds CAPVAXIVE to Publicly Funded Adult Immunization Program More Info:"
X Link 2025-12-08T15:15Z 3010 followers, XXX engagements

"$HRMY -XXXX% today as Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome More Info:"
X Link 2025-12-08T15:15Z 3014 followers, XXX engagements

"$PCVX +1.36% today as Vaxcyte Doses First Participants in the OPUS Phase X Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults More Info:"
X Link 2025-12-08T15:15Z 3010 followers, XXX engagements

"$SABS -XXXX% today as SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management More Info:"
X Link 2025-12-08T15:15Z 3013 followers, XXX engagements

"$CHRS +8.16% today as Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma More Info:"
X Link 2025-12-08T15:15Z 3013 followers, XXX engagements

"$BMEA Biomea Fusion presented P2 Type X Diabetes results on 2025-12-05 for Icovamenib More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements

"$ORIC Oric presented P1 Non-Small-Cell Lung Cancer results on 2025-12-06 for Enozertinib More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements

"$PRTC PureTech presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-05 for LYT-200 More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements

"$XENE Xenon presented P3 Epilepsy results on 2025-12-06 for Azetukalner More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements

"$DERM -XXXX% today as Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology More Info:"
X Link 2025-12-10T14:42Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $CELC Celcuity will present Phase X Breast Cancer Data for Gedatolisib (PI3K Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-10T11:12Z 3018 followers, XXX engagements

"$LLY +2.48% today as Lilly's triple agonist retatrutide delivered weight loss of up to an average of XXXX lbs along with substantial relief from osteoarthritis pain in first successful Phase X trial More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XX engagements

"$ATAI +1.61% today as AtaiBeckley Announces New U.S. Patent Granted for EMP-01 Strengthening Intellectual Property Portfolio More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XX engagements

"$BYSI +5.54% today as BeyondSpring Announces New Analyses of DUBLIN-3 Phase X Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XX engagements

"PharmaEssentia emphasizes BESREMi availability for patients impacted by Pegasys drug shortage. More Info: $XBI $IBB $XPH $PPH"
X Link 2025-03-04T16:35Z 3014 followers, XXX engagements

"$ACET Adicet Bio dosed the first Systemic Sclerosis patient in Phase X trial of ADI-001 for Autoimmune Diseases. More Info: $XBI $IBB $XPH $PPH"
X Link 2025-07-24T11:02Z 3014 followers, XXX engagements

"$PRTA +1.14% today as Prothena Highlights Phase X Data for Coramitug (Formerly PRX004) Published in Circulation Official Journal of AHA More Info:"
X Link 2025-11-11T18:33Z 3014 followers, XXX engagements

"$GMAB -XXXX% today as Genmab Announces EPKINLY (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma More Info:"
X Link 2025-11-18T17:31Z 3014 followers, XXX engagements

"$NBIX +0.55% today as Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA (valbenazine) Capsules More Info:"
X Link 2025-11-20T14:41Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $CGON CG Oncology will present Phase X Bladder Cancer Data for Cretostimogene grenadenorepvec (Gene TherapyGM-CSF - Gene Therapy) tomorrow 👀"
X Link 2025-12-04T11:12Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $GMAB Genmab will present Phase X Diffuse Large B-Cell Lymphoma Data for Epcoritamab (CD20 BinderCD3 Binder - Bispecific Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LEGN Legend Biotech will present Phase X Lymphoma Non-Hodgkin Data for Ciltacabtagene autoleucel (CAR-TBCMA - Autologous CAR-T) tomorrow 👀"
X Link 2025-12-05T11:12Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $AGIO Agios will present Phase X alpha-Thalassemiabeta-Thalassemia Data for Mitapivat (PKR Activator - Small Molecule) tomorrow 👀"
X Link 2025-12-07T11:12Z 3014 followers, XXX engagements

"$PRTC +4.81% today as PureTech Announces Successful End-of-Phase X Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis More Info:"
X Link 2025-12-08T15:14Z 3014 followers, XXX engagements

"$CASI -XXXX% today as CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting More Info:"
X Link 2025-12-08T15:15Z 3014 followers, XXX engagements

"$MNOV -XXXX% today as MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND More Info:"
X Link 2025-12-08T15:15Z 3014 followers, XXX engagements

"$ALPMY Astellas Pharma presented P3 Acute Myeloid Leukemia results on 2025-12-06 for Gilteritinib More Info:"
X Link 2025-12-08T21:23Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LLY Eli Lilly will present Phase X Breast Cancer Data for Tersolisib (PI3K Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-09T11:12Z 3014 followers, XXX engagements

"$COYA +1.89% today as Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA XXX for the Treatment of ALS More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$ENVB +2.04% today as Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$ATOS +2.76% today as Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$CLDX -XXXX% today as Celldex Initiates Global Registrational Phase X Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$AKTX -XXXX% today as Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate AKTX-101 for Hard-to-Treat K-Ras Mutant Pancreatic Cancer More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$PTIX -XXXX% today as Results from Phase X Multiple-Dose Study of PT00114 More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$BMY -XXXX% today as BioNTech and Bristol Myers Squibb Present First Global Phase X Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$SNTI -XXXX% today as Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase X Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients Demonstrating Deep MRD Negative Durable Complete Remissions and a Favorable Safety Profile More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$SNTI -XXXX% today as Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$MRK -XXXX% today as Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in US and Canada More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$ENSC -XXXXX% today as Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase X Trial of PF614 Its Next-Generation Opioid More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$GLMD Galmed announced they will present P1 Hepatocellular Carcinoma results on 2025-12-09 for Aramchol More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XXX engagements

"$KYMR Kymera Therapeutics announced they will present P2 Dermatitis Atopic results in 3Q27 for KT-621 More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XX engagements

"$CASI CASI presented P1 Thrombocytopenia results on 2025-12-08 for CID-103 More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XX engagements

"$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XXX engagements

"$CGEM Cullinan Oncology presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-08 for CLN-049 More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XXX engagements

"$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XXX engagements

"$KZIA -XXXXX% today as Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+ More Info:"
X Link 2025-12-10T14:42Z 3014 followers, XXX engagements

"$PTCT +0.84% today as PTC Therapeutics Announces Health Canada Approval of Sephience (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) More Info:"
X Link 2025-12-10T14:42Z 3014 followers, XXX engagements

"$RHHBY -XXXX% today as Roche's giredestrant reduced risk of invasive disease recurrence or death by XX% in ER-positive early-stage breast cancer More Info:"
X Link 2025-12-10T14:42Z 3014 followers, XXX engagements

"$OSTX +2.08% today as OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonary Metastatic Osteosarcoma More Info:"
X Link 2025-12-09T15:58Z 3018 followers, XXX engagements

"$LXRX +1.14% today as Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase X (ACSL5) Reinforcing the Scientific Rationale for LX9851 More Info:"
X Link 2025-12-10T14:42Z 3018 followers, XXX engagements

"$GNFT as GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy More Info:"
X Link 2025-12-10T20:43Z 3018 followers, XXX engagements

"$KYMR -XXXX% today as Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621 a First-in-Class Oral STAT6 Degrader for the Treatment of Atopic Dermatitis More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XX engagements

"$ACIU +13.20% today as AC Immune Positive Interim Phase X Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson's Disease More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XX engagements

"$ATOS +8.01% today as Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XXX engagements

"$PRAX +2.01% today as Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026 More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XXX engagements

"$GRI GRI Bio presented P2 Idiopathic Pulmonary Fibrosis results on 2025-12-10 for GRI-0621 More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XXX engagements

"$LXRX Lexicon presented P0 Obesity results on 2025-12-10 for LX-9851 More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XXX engagements

"$PFE Pfizer presented P3 Breast Cancer results on 2025-12-09 for Tucatinib More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XXX engagements

"$GERN +1.90% today as Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO (Imetelstat) in Lower-Risk MDS More Info:"
X Link 2025-12-08T15:15Z 3018 followers, XXX engagements

"$CRBP Corbus announced they will present P1 Obesity results on 2025-12-11 for CRB-913 More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XXX engagements

"$RNAZ +7.41% today as TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138 following positive readouts from TransCode's Phase X trial More Info:"
X Link 2025-12-11T17:37Z 3018 followers, XXX engagements

"$TNYA -XXXX% today as Tenaya Therapeutics Reports Positive Interim Data from Cohort X of RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC More Info:"
X Link 2025-12-11T22:01Z 3018 followers, XXX engagements

"$LYRA Lyra Therapeutics announced they will present Phase X Sinusitis results on 2025-10-13 for Mometasone furoate More Info:"
X Link 2025-10-08T01:56Z 3014 followers, XXX engagements

"$ONC +2.86% today as BeOne Medicines' Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA More Info:"
X Link 2025-10-13T15:06Z 3017 followers, XXX engagements

"$FBIO -XXXX% today as Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics' Global Phase X Trials of Dotinurad for the Treatment of Gout More Info:"
X Link 2025-10-21T13:57Z 3014 followers, XXX engagements

"$ZLAB Zai Lab announced they will present P1 Dermatitis Atopic results in YE26 for ZL-1503 More Info:"
X Link 2025-11-07T21:35Z 3014 followers, XXX engagements

"$IONS -XXXX% today as Ionis receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia (sHTG) More Info:"
X Link 2025-12-01T15:46Z 3014 followers, XXX engagements

"$JAZZ Jazz announced they will present P3 Gastrointestinal Cancer results on 2026-01-09 for Zanidatamab More Info:"
X Link 2025-12-03T20:59Z 3014 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ACLX Arcellx will present Phase X Multiple Myeloma Data for Anitocabtagene autoleucel (CAR-TBCMA - Autologous CAR-T) tomorrow 👀"
X Link 2025-12-05T11:12Z 3017 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $CASI CASI will present Phase X Thrombocytopenia Data for CID-103 (CD38 Inhibitor - Antibody) tomorrow 👀"
X Link 2025-12-06T11:12Z 3014 followers, XXX engagements

"$ZLAB -XXXX% today as Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503 an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis More Info:"
X Link 2025-12-08T15:15Z 3014 followers, XXX engagements

"$PDSB +17.13% today as PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$LLY -XXXX% today as Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival reducing the risk of progression or death by XX% versus chemoimmunotherapy in patients with treatment-nave CLL/SLL More Info:"
X Link 2025-12-09T15:58Z 3014 followers, XXX engagements

"$COGT Cogent Biosciences presented P2 Mastocytosis Systemic results on 2025-12-08 for Bezuclastinib More Info:"
X Link 2025-12-09T18:29Z 3017 followers, XXX engagements

"$FATE Fate presented P0 Autoimmune Disease Unspecified results on 2025-12-08 for FT-839 More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XXX engagements

"$FATE Fate presented P0 Multiple Myeloma results on 2025-12-08 for FT-836 More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XXX engagements

"$FATE Fate presented P1 Lupus Erythematosus Systemic results on 2025-12-08 for FT-819 More Info:"
X Link 2025-12-09T18:29Z 3014 followers, XXX engagements

"$GLPG Galapagos presented P2 Mantle-Cell Lymphoma results on 2025-12-08 for GLPG-5101 More Info:"
X Link 2025-12-09T18:30Z 3018 followers, XXX engagements

"$GMAB Genmab presented P1 Chronic Lymphoid Leukemia results on 2025-12-08 for Epcoritamab More Info:"
X Link 2025-12-09T18:30Z 3017 followers, XXX engagements

"$RHHBY Hoffmann-La Roche presented P3 Diffuse Large B-Cell Lymphoma results on 2025-12-08 for Glofitamab More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XX engagements

"$RHHBY Hoffmann-La Roche presented P3 Follicular Lymphoma results on 2025-12-08 for Mosunetuzumab More Info:"
X Link 2025-12-09T18:30Z 3016 followers, XXX engagements

"$INCY Incyte presented P1 Myeloproliferative Disorders results on 2025-12-08 for INCA-033989 More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XXX engagements

"$IVBIY Innovent presented P3 Psoriasis results on 2025-12-08 for Picankibart More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XX engagements

"$KYMR Kymera Therapeutics presented P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XX engagements

"$NRIX Nurix Therapeutics presented P1 Waldenstrom Macroglobulinemia results on 2025-12-08 for Bexobrutideg More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XXX engagements

"$RXRX Recursion Pharmaceuticals presented P2 Familial Adenomatous Polyposis results on 2025-12-08 for REC-4881 More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XXX engagements

"$GPCR Structure Therapeutics presented P2 Obesity results on 2025-12-08 for Aleniglipron More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XXX engagements

"$SNDX Syndax presented P2 Acute Myeloid Leukemia results on 2025-12-08 for Revumenib More Info:"
X Link 2025-12-09T18:30Z 3014 followers, XXX engagements

"$PRAX -XXXX% today as Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy More Info:"
X Link 2025-12-09T21:20Z 3015 followers, XXX engagements

"$KYMR Kymera Therapeutics announced they will present P2 Dermatitis Atopic results in 3Q27 for KT-621 More Info:"
X Link 2025-12-09T21:20Z 3014 followers, XX engagements

"$CASI CASI presented P1 Thrombocytopenia results on 2025-12-08 for CID-103 More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XX engagements

"$COGT Cogent Biosciences presented P2 Mastocytosis Systemic results on 2025-12-08 for Bezuclastinib More Info:"
X Link 2025-12-09T21:21Z 3017 followers, XXX engagements

"$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$CGEM Cullinan Oncology presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-08 for CLN-049 More Info:"
X Link 2025-12-09T21:21Z 3016 followers, XXX engagements

"$FATE Fate presented P0 Autoimmune Disease Unspecified results on 2025-12-08 for FT-839 More Info:"
X Link 2025-12-09T21:21Z 3016 followers, XXX engagements

"$FATE Fate presented P1 Lupus Erythematosus Systemic results on 2025-12-08 for FT-819 More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$GMAB Genmab presented P1 Chronic Lymphoid Leukemia results on 2025-12-08 for Epcoritamab More Info:"
X Link 2025-12-09T21:21Z 3017 followers, XXX engagements

"$RHHBY Hoffmann-La Roche presented P3 Diffuse Large B-Cell Lymphoma results on 2025-12-08 for Glofitamab More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$RHHBY Hoffmann-La Roche presented P3 Follicular Lymphoma results on 2025-12-08 for Mosunetuzumab More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$INCY Incyte presented P1 Myeloproliferative Disorders results on 2025-12-08 for INCA-033989 More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$IVBIY Innovent presented P3 Psoriasis results on 2025-12-08 for Picankibart More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$KYMR Kymera Therapeutics presented P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$RXRX Recursion Pharmaceuticals presented P2 Familial Adenomatous Polyposis results on 2025-12-08 for REC-4881 More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$GPCR Structure Therapeutics presented P2 Obesity results on 2025-12-08 for Aleniglipron More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$SNDX Syndax presented P2 Acute Myeloid Leukemia results on 2025-12-08 for Revumenib More Info:"
X Link 2025-12-09T21:21Z 3014 followers, XXX engagements

"$WVE Wave Life Sciences presented P1 Obesity results on 2025-12-08 for INHBE More Info:"
X Link 2025-12-09T21:21Z 3016 followers, XXX engagements

"$SGMT +4.02% today as Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40) a First-in-Class FASN Inhibitor for Acne Treatment More Info:"
X Link 2025-12-10T14:42Z 3018 followers, XXX engagements

"$MDNA as Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025 Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors More Info:"
X Link 2025-12-10T14:42Z 3017 followers, XXX engagements

"$FBLG +3.57% today as FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions More Info:"
X Link 2025-12-10T14:42Z 3018 followers, XXX engagements

"$RHHBY -XXXX% today as Genentech's Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by XX% in ER-positive Early-Stage Breast Cancer More Info:"
X Link 2025-12-10T14:42Z 3017 followers, XXX engagements

"$BRNS +7.75% today as Barinthus Bio Announces Update on Phase X AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease More Info:"
X Link 2025-12-10T14:42Z 3014 followers, XX engagements

"$PFE -XXXX% today as TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over X Months in Patients with HER2+ Metastatic Breast Cancer More Info:"
X Link 2025-12-10T14:42Z 3014 followers, XXX engagements

"$NVS Novartis presented P3 Breast Cancer results on 2025-12-09 for Ribociclib More Info:"
X Link 2025-12-10T20:43Z 3017 followers, XXX engagements

"$MAIA +8.09% today as MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase X Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer More Info:"
X Link 2025-12-11T17:37Z 3017 followers, XX engagements

"$ALPMY Astellas Pharma presented P2 Gastrointestinal Cancer results on 2025-01-08 for Zolbetuximab More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XX engagements

"$BRNS Barinthus Biotherapeutics presented P1 Celiac Disease results on 2025-12-10 for VTP-1000 More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XX engagements

"$RHHBY Hoffmann-La Roche presented P3 Breast Cancer results on 2025-12-10 for Giredestrant More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XX engagements

"$DERM Journey Medical presented P1 Rosacea results on 2025-12-10 for DFD-29 More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XXX engagements

"$KZIA Kazia Therapeutics presented P1 Triple Negative Breast Cancer results on 2025-12-10 for Paxalisib More Info:"
X Link 2025-12-11T18:33Z 3017 followers, XXX engagements

"$NCNA Nucana presented P2 Melanoma results on 2025-12-10 for Fosdesdenosine sipalabenamide More Info:"
X Link 2025-12-11T18:33Z 3018 followers, XXX engagements

"$AGIO +0.87% today as Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia More Info:"
X Link 2025-12-08T15:15Z 3018 followers, XXX engagements

"$CRVS -XXXX% today as Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial More Info:"
X Link 2025-12-08T21:23Z 3018 followers, XXX engagements

"$APVO -XXXX% today as Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025 More Info:"
X Link 2025-12-09T15:58Z 3018 followers, XXX engagements

"$AUTL Autolus Limited presented P1 Acute LeukemiaB-Cell Leukemia results on 2025-12-08 for Obecabtagene autoleucel More Info:"
X Link 2025-12-09T18:29Z 3018 followers, XXX engagements

"$GERN Geron presented P3 Myelodysplastic Syndrome results on 2025-12-08 for Imetelstat More Info:"
X Link 2025-12-09T18:30Z 3018 followers, XXX engagements

"$MNOV MediciNova presented P2 Amyotrophic Lateral Sclerosis results on 2025-12-08 for Ibudilast More Info:"
X Link 2025-12-09T18:30Z 3018 followers, XX engagements

"$SABS SAb Biotherapeutics presented P1 Type X Diabetes results on 2025-12-08 for SAB-142 More Info:"
X Link 2025-12-09T18:30Z 3018 followers, XXX engagements

"$TERN Terns presented P1 Chronic Myeloid Leukemia results on 2025-12-08 for TERN-701 More Info:"
X Link 2025-12-09T18:30Z 3018 followers, XXX engagements

"$WVE Wave Life Sciences presented P1 Obesity results on 2025-12-08 for INHBE More Info:"
X Link 2025-12-09T18:30Z 3018 followers, XXX engagements

"$GLMD Galmed announced they will present P1 Hepatocellular Carcinoma results on 2025-12-09 for Aramchol More Info:"
X Link 2025-12-09T21:20Z 3018 followers, XXX engagements

"$AUTL Autolus Limited presented P1 Acute LeukemiaB-Cell Leukemia results on 2025-12-08 for Obecabtagene autoleucel More Info:"
X Link 2025-12-09T21:21Z 3018 followers, XXX engagements

"$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:"
X Link 2025-12-09T21:21Z 3018 followers, XXX engagements

"$FATE Fate presented P0 Multiple Myeloma results on 2025-12-08 for FT-836 More Info:"
X Link 2025-12-09T21:21Z 3018 followers, XXX engagements

"$GLPG Galapagos presented P2 Mantle-Cell Lymphoma results on 2025-12-08 for GLPG-5101 More Info:"
X Link 2025-12-09T21:21Z 3018 followers, XXX engagements

"$GERN Geron presented P3 Myelodysplastic Syndrome results on 2025-12-08 for Imetelstat More Info:"
X Link 2025-12-09T21:21Z 3018 followers, XXX engagements

"$MNOV MediciNova presented P2 Amyotrophic Lateral Sclerosis results on 2025-12-08 for Ibudilast More Info:"
X Link 2025-12-09T21:21Z 3018 followers, XXX engagements

"$NRIX Nurix Therapeutics presented P1 Waldenstrom Macroglobulinemia results on 2025-12-08 for Bexobrutideg More Info:"
X Link 2025-12-09T21:21Z 3018 followers, XXX engagements